OPKO Health (OPK): Price-to-Projected Revenue Ratio

Corporate emblem and logo of OPKO Health (OPK)

The forward P/S valuation visualizes the ratio of OPKO Health, Inc. (OPK) market capitalization to projected revenue, where the value 2.40 reflects this status. The business faces logistics disruptions and patent complexities resulting from global conflicts. High confidence in BioReference in the US is coupled with management's expectation of a swift recovery in profitability following aggressive cost optimization.

OPK (opko.com) Forward Price to Sales history from 07/04/2022 to 11/14/2026

OPK (OPKO Health Corp.): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart OPKO Health|OPK - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value OPKO Health Corp.|OPK - Total Enterprise Value
- book value of equity indicators:
Accounting Value per Share OPKO Health|OPK - Accounting Value of Company|Market Capitalization to Book Value Ratio opko.com|OPK - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital OPKO Health, Inc.|OPK - Long-Term Liabilities to Capital|Short-Term Debt to Capital OPKO Health, Inc.|OPK - Company Aggregate Debts|Debt to Book Capitalization Ratio OPKO Health Corp.|OPK - Company Long-Term Debt|Company Current Liabilities OPKO Health|Quick Ratio opko.com
- net income and valuation multiples indicators:
OPK - Final Profit|Future Profit OPKO Health, Inc.|OPK - Company Value to Net Income|Forward P/E Multiple OPKO Corp|OPK - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPKO Health Corp.|OPK - Operating profit before amortization|Net earnings per share (EPS TTM) OPKO Health|OPK - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months opko.com|OPK - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year OPKO Health, Inc.
- company sales and revenue statistics:
OPK - Company Total Revenue|Company Projected Revenue OPKO Health|OPK - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio OPKO Health Corp.
Fundamental company analysis:OPK (OPKO Health)
Product sample of OPKO Health Corp.

The restructuring of BioReference and the expansion of Rayaldee make the forward P/S of the business a key indicator of capital reallocation efficiency for OPKO Health, Inc. (OPK). This metric determines the company's market value relative to expected future sales volumes, neutralizing the time lags associated with quarterly reports. The calculation is based on the ratio of current market capitalization to projected annual revenue. An increase in this indicator signals market optimism, although it requires confirmation through the actual operational recovery of the holding.

Who OPKO Health, Inc. competes with

Price-to-Projected Revenue Ratio Agilent A|Forward P/S Multiple Quest Diagnostics Inc. DGX|ILMN - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Exact Sciences Inc.|RVTY (Revvity, Inc.) - Forward Price-to-Revenue Multiple|bio-rad.com - Forward Price to Sales|NNNN (Anbio) - Forward P/S Multiple|SHC: Forward Price to Sales|Forward P/S Multiple QDEL|CDNA - Market Cap to Future Revenue Ratio|Forward P/S Multiple MRVI (Maravai LifeSciences)|Forward P/S Multiple fulgentgenetics.com FLGT|LAB - Price-to-Projected Revenue Ratio|CTKB: Price-to-Projected Revenue Ratio|OSUR (OraSure Technologies Inc) - Forward Price-to-Revenue Multiple|XGN: Price to Expected Revenue Ratio|MDXH (MDxHealth SA) - Forward P/S Multiple|LUCD: Forward Price to Sales|Forward Price-to-Revenue Multiple PRE (Prenetics Global)|IMDX (imdxinc.com) - Forward Price to Sales|Forward P/S Multiple TRIB (Trinity Biotech)|Market Cap to Expected Sales Ratio ProPhase Labs Corp (PRPH)|AIMD - Price-to-Projected Revenue Ratio|CODX (codiagnostics.com) - Market Cap to Projected Revenue|HSCS: Forward P/S Multiple|Forward Price-to-Revenue Multiple Biomerica Inc.|Forward Price-to-Revenue Multiple CDIO|Onconetix Corporation (ONCO) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Virax Biolabs Group (VRAX)|BJDX - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Aspira Women's Health Inc. AWH|AXDX (Accelerate Diagnostics Inc.) - Future Price to Revenue|CNTG - Price-to-Projected Revenue Ratio|ENZ - Forward P/S Multiple|fresh2.co (FRES) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Genetic Technologies Limited|ME (23andMe) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Psychemedics Corp. PMD